Nasal Drug Delivery Technology

Nasal Drug Delivery Technology

Global Nasal Drug Delivery Technology Market to Reach $94.2 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Nasal Drug Delivery Technology estimated at US$66.4 Billion in the year 2020, is projected to reach a revised size of US$94.2 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Nasal Sprays, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$50 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Drops & Liquids segment is readjusted to a revised 4.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $19.6 Billion, While China is Forecast to Grow at 4.8% CAGR

The Nasal Drug Delivery Technology market in the U.S. is estimated at US$19.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$16.6 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Other Dosage Forms Segment to Record 3.8% CAGR

In the global Other Dosage Forms segment, USA, Canada, Japan, China and Europe will drive the 3.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.5 Billion in the year 2020 will reach a projected size of US$7.2 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 47 Featured) -

  • 3M Company
  • Aegis Therapeutics LLC
  • Aptargroup, Inc.
  • AstraZeneca PLC
  • GlaxoSmithKline PLC
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Nasal Drug Delivery Technology – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Nasal Drug Delivery Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Nasal Drug Delivery Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Nasal Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Nasal Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Nasal Sprays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Recent Past, Current & Future Analysis for Drops & Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 8: World Historic Review for Drops & Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 9: World 15-Year Perspective for Drops & Liquids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 10: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 11: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 12: World 15-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 13: World Recent Past, Current & Future Analysis for Multi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 14: World Historic Review for Multi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 15: World 15-Year Perspective for Multi-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 16: World Recent Past, Current & Future Analysis for Unit-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 17: World Historic Review for Unit-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 18: World 15-Year Perspective for Unit-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 19: World Recent Past, Current & Future Analysis for Bi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 20: World Historic Review for Bi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 21: World 15-Year Perspective for Bi-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 22: World Recent Past, Current & Future Analysis for Allergic & Non-allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 23: World Historic Review for Allergic & Non-allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 24: World 15-Year Perspective for Allergic & Non-allergic Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 25: World Recent Past, Current & Future Analysis for Nose Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 26: World Historic Review for Nose Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 27: World 15-Year Perspective for Nose Congestion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 28: World Recent Past, Current & Future Analysis for Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 29: World Historic Review for Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 30: World 15-Year Perspective for Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 31: World Recent Past, Current & Future Analysis for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 32: World Historic Review for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 33: World 15-Year Perspective for Other Therapeutic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 34: World Recent Past, Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 35: World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 36: World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 37: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 38: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 39: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 40: World Nasal Drug Delivery Technology Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 41: USA Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 42: USA Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 43: USA 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 44: USA Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 45: USA Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 46: USA 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 47: USA Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 48: USA Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 49: USA 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 50: USA Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 51: USA Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 52: USA 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
CANADA
TABLE 53: Canada Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 54: Canada Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 55: Canada 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 56: Canada Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 57: Canada Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 58: Canada 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 59: Canada Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 60: Canada Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 61: Canada 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 62: Canada Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 63: Canada Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 64: Canada 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
JAPAN
Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 65: Japan Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 66: Japan Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 67: Japan 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 68: Japan Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 69: Japan Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 70: Japan 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 71: Japan Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 72: Japan Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 73: Japan 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 74: Japan Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 75: Japan Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 76: Japan 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
CHINA
Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 77: China Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 78: China Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 79: China 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 80: China Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 81: China Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 82: China 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 83: China Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 84: China Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 85: China 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 86: China Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 87: China Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 88: China 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
EUROPE
Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 89: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 90: Europe Historic Review for Nasal Drug Delivery Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 91: Europe 15-Year Perspective for Nasal Drug Delivery Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 92: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 93: Europe Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 94: Europe 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 95: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 96: Europe Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 97: Europe 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 98: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 99: Europe Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 100: Europe 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 101: Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 102: Europe Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 103: Europe 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
FRANCE
Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 104: France Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 105: France Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 106: France 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 107: France Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 108: France Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 109: France 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 110: France Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 111: France Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 112: France 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 113: France Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 114: France Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 115: France 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
GERMANY
Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 116: Germany Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 117: Germany Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 118: Germany 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 119: Germany Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 120: Germany Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 121: Germany 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 122: Germany Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 123: Germany Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 124: Germany 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 125: Germany Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 126: Germany Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 127: Germany 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
ITALY
TABLE 128: Italy Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 129: Italy Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 130: Italy 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 131: Italy Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 132: Italy Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 133: Italy 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 134: Italy Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 135: Italy Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 136: Italy 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 137: Italy Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 138: Italy Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 139: Italy 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
UNITED KINGDOM
Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 140: UK Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 141: UK Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 142: UK 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 143: UK Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 144: UK Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 145: UK 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 146: UK Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 147: UK Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 148: UK 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 149: UK Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 150: UK Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 151: UK 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 153: Rest of Europe Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 154: Rest of Europe 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 156: Rest of Europe Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 157: Rest of Europe 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 159: Rest of Europe Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 160: Rest of Europe 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 161: Rest of Europe Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 162: Rest of Europe Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 163: Rest of Europe 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Nasal Drug Delivery Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 165: Asia-Pacific Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 166: Asia-Pacific 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 168: Asia-Pacific Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 169: Asia-Pacific 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 171: Asia-Pacific Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 172: Asia-Pacific 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 173: Asia-Pacific Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 174: Asia-Pacific Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 175: Asia-Pacific 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 176: Rest of World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 177: Rest of World Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 178: Rest of World 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2021 & 2027
TABLE 179: Rest of World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 180: Rest of World Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 181: Rest of World 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2021 & 2027
TABLE 182: Rest of World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 183: Rest of World Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 184: Rest of World 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2021 & 2027
TABLE 185: Rest of World Recent Past, Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 186: Rest of World Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 187: Rest of World 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings